In a brief filed earlier this week, the US Department of Justice (DOJ) is asking the US Supreme Court to let stand its Second Circuit loss in a lawsuit against American Express over the company’s merchant anti-steering rules
The Ohio attorney general’s office and another 10 states appealed a federal court’s decision allowing American Express to bar merchants from steering customers to lower-priced credit cards. In June, the Justice Department opted not to appeal the ruling.
The acting solicitor general’s brief arguing against a Supreme Court review, is the first time the federal government has explained why it didn’t pursue an appeal of a major court loss.
The DOJ asked the justices to turn down a petition for certiorari filed in June by 11 states after the federal government decided not to pursue its own appeal of the Second Circuit’s September ruling. The brief said, neither the Supreme Court nor circuit courts have “squarely considered” the application of antitrust laws to two-sided markets. For that reason, the high court shouldn’t accept a petition for writ of certiorari.
“The court of appeals seriously departed from sound antitrust principles, and its decision leaves in place restraints that thwart price competition in an important sector of the economy and inflate the retail prices paid by all consumers,” the brief said.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas